Search Results - Larry Tsai
- Showing 1 - 13 results of 13
-
1
-
2
IGNITE4: Results of a Phase 3, Randomized, Multicenter, Prospective Trial of Eravacycline vs Meropenem in the Treatment of Complicated Intraabdominal Infections by Joseph S. Solomkin, Jānis Gardovskis, Kenneth Lawrence, Philippe Montravers, Angie Sway, David C. Evans, Larry Tsai
Published 2018Artigo -
3
-
4
-
5
-
6
-
7
-
8
Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial by Iván O. Rosas, George Diaz, Robert Gottlieb, Suzana M. Lobo, Philip A. Robinson, Bradley D. Hunter, Adilson W. Cavalcante, J. Scott Overcash, Nicola A. Hanania, Alan P Skarbnik, Julia Garcia‐Diaz, И. Г. Гордеев, Jordi Carratalà, Oliver Gordon, Emily Graham, Nicholas Lewin‐Koh, Larry Tsai, Katie Tuckwell, Huyen Cao, Diana M. Brainard, Julie Olsson
Published 2021Artigo -
9
Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia by Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Mariam Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracián, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, Atul Malhotra
Published 2020Pré-impressão -
10
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia by Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Mariam Aziz, Nichola Cooper, Ivor S. Douglas, Sinisa Savic, Taryn Youngstein, Lorenzo Del Sorbo, Antonio Cubillo Gracián, David J. De La Zerda, Andrew Ustianowski, Min Bao, Sophie Dimonaco, Emily Graham, Balpreet Matharu, Helen Spotswood, Larry Tsai, Atul Malhotra
Published 2021Artigo -
11
Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial* by Jennifer Tom, Min Bao, Larry Tsai, Aditi Qamra, David Summers, Montserrat Carrasco‐Triguero, Jacqueline McBride, Carrie M. Rosenberger, Celia J. F. Lin, William Stubbings, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick S. Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Farrah Kheradmand, Iván O. Rosas, Fang Cai
Published 2021Artigo -
12
A randomised trial of lung sealant <i>versus</i> medical therapy for advanced emphysema by Carolyn E. Come, Mordechai R. Kramer, Mark T. Dransfield, Muhanned Abu‐Hijleh, David Berkowitz, Michela Bezzi, Surya P. Bhatt, Michael Boyd, Enrique Cases, Alexander C. Chen, Christopher B. Cooper, Javier Flandes, Thomas R. Gildea, Mark H. Gotfried, D. Kyle Hogarth, Kumaran Kolandaivelu, William Leeds, Timothy Liesching, Nathaniel Marchetti, Charles‐Hugo Marquette, Richard A. Mularski, Víctor Pinto-Plata, Michael A. Pritchett, Samaan Rafeq, Edmundo Rubio, Dirk‐Jan Slebos, Grigoris Stratakos, Alexander M. Sy, Larry Tsai, Momen M. Wahidi, John Walsh, J. Michael Wells, Patrick Whitten, Roger D. Yusen, Javier J. Zulueta, Gerard J. Criner, George R. Washko
Published 2015Artigo -
13
Tocilizumab in patients hospitalised with COVID-19 pneumonia: Efficacy, safety, viral clearance, and antibody response from a randomised controlled trial (COVACTA) by Iván O. Rosas, Norbert Bräu, Michael R. Waters, Ronaldo C. Go, Atul Malhotra, Bradley D. Hunter, Sanjay Bhagani, Daniel J. Skiest, Sinisa Savic, Ivor S. Douglas, Julia Garcia‐Diaz, Mariam Aziz, Nichola Cooper, Taryn Youngstein, Lorenzo Del Sorbo, David J. De La Zerda, Andrew Ustianowski, Antonio Cubillo Gracián, Kevin G. Blyth, Jordi Carratalà, Bruno François, Thomas Benfield, Derrick S. Haslem, Paolo Bonfanti, Cor H. van der Leest, Nidhi Rohatgi, Lothar Wiese, Charles Edouard Luyt, Rebecca N. Bauer, Fang Cai, Ivan T. Lee, Balpreet Matharu, Louis M. Metcalf, Steffen Wildum, Emily Graham, Larry Tsai, Min Bao
Published 2022Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Pathology
Randomized controlled trial
Disease
Lung
Surgery
Tocilizumab
Adverse effect
Coronavirus disease 2019 (COVID-19)
Environmental health
Infectious disease (medical specialty)
Pneumonia
Population
Alternative medicine
Biology
Confidence interval
Intensive care medicine
Placebo
Rheumatoid arthritis
2019-20 coronavirus outbreak
Cell
Cell biology
Clinical endpoint
Cohort
Comorbidity
Emergency medicine
Odds ratio
Outbreak
Pediatrics